Brokerages Set Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Target Price at $49.60
Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Rating) have been assigned an average recommendation of “Buy” from the six ratings firms that are currently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation, four have given a buy recommendation and one has given a strong […]